Mitochondria HSP90: The target to inactivate in cancer therapy?;HSP90 mitochondriale la cible à inactiver dans la thérapie anti-cancéreuse?

Medecine/Sciences

Volumn 24, Issue 4, 2008, Pages 363-364

  Didelot, Céline ^a   Garrido, Carmen ^a  

^a Chu   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN D; CYCLOSPORIN A; GLUCOSE REGULATED PROTEIN 94; HEAT SHOCK PROTEIN 90;

CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; MITOCHONDRION; NOTE; PROTEIN EXPRESSION;

EID: 42449147570     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2008244363     Document Type: Note

References (8)

1. Arrigo AP. Chaperons moléculaires et repliement des protéines : l'exemple de certaines protéines de choc thermique. Med Sci (Paris) 21 : 619-25.
2. Didelot C, Lanneau D, Brunet M, et al. Anti-cancer therapeutics approaches based on intercellular and extracellular heat shock proteins. Curr Med Chem 2007 ; 14 : 2839-47.
3. Kang BH, Plescia J, Dohi T, et al. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 2007 ; 131 : 257-70.
4. Joliot A, Prochiantz A. Peptides transducteurs : la face utile d'un nouveau mode de signalisation. Med Sci (Paris) 2005 ; 21 : 309-14.
5. Schmitt E, Gehrmann M, Brunet M, et al. Intracellular and extracellular functions of HSPs: repercussions in cancer therapy. J Leuk Biol 2007 ; 81 : 15-27.
6. Kamal A, Thao L, Sensintaffar J, et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003 ; 425 : 407-10.
7. Didelot C, Lanneau D, Brunet M, et al. HSP90beta by chaperoning c-IAP1 plays an essential role in cell differentiation. Cell Death Diff 2008 (sous presse).
8. Garrido C, Galluzzi L, Brunet M, et al. Mechanisms of cytochrome c release from mitochondria. Cell Death Diff 2006 ; 13 : 1423-33.